Пређи на садржај

Онкологија

Мултимодални, интердисциплинарни и индивидуализовани приступ

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (отвара нови прозор)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Извор‎: J Surg Oncol 2007;96(3):249-53.

Индекс‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (отвара нови прозор)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (отвара нови прозор)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Извор‎: Transfusion 2016;56(10):2438-42.

Индекс‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (отвара нови прозор)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (отвара нови прозор)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Извор‎: Oncologist 2016;21(3):327-32.

Индекс‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (отвара нови прозор)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (отвара нови прозор)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Извор‎: J Am Coll Surg 2013;217(6):1101-7.

Индекс‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (отвара нови прозор)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (отвара нови прозор)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Извор‎: Leuk Res Rep. 2022 25;18:100355.

Индекс‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (отвара нови прозор)